Global Statistics Representing Breast Implants Market Scenario
A breast implant is a prosthesis used to change the size, shape, and contour of a woman’s breast. Breast implants are inserted to increase the size of the breasts, change their shape or make them level. Reconstructive plastic surgery is done to restore a natural-looking breast mound in post–mastectomy breast reconstruction patients or to correct congenital defects and deformities of the chest wall. Cosmetic surgery is done to enhance or enlarge the appearance of the breast through breast augmentation.
Increasing incidences of breast cancer are the key factor supporting the growth of the breast implants market. According to National Cancer Registry, by 2020, there will be approximately 5,000 new cases of breast cancer in Ireland per annum. As per the American Cancer Society, more than 266,120 new cases of breast cancer were registered in the U.S. alone in 2018. Mastectomy is usually carried out to treat breast cancer and the desire to restore aesthetic appeal among patients will further drive the market growth of breast implants. Additionally, R&D initiatives and technological advancements, alongside increasing disposable income are also expected to contribute to market growth.
On the other hand, the risk of developing serious complications and lack of skilled nursing facilities in emerging markets may hamper the growth of the breast implants market.
Global breast implants market is valued at USD 488 million in 2018, growing at a CAGR of 6.8% during the forecast period 2019-2026.
The global breast implants market can be segmented on the basis of product, application, end user, and region.
Based on product, the market can be segmented into saline and silicone. Amongst the segments by product, silicone is expected to record the highest growth during the forecast period, 2019–2026. The saline segment is expected to witness rapid growth, owing to the increase preference towards saline breast implants among women.
Based on application, the market can be segmented into breast augmentation and breast reconstruction. Amongst the segments by application, breast augmentation is expected to account for the largest market share, owing to the increasing number of breast cosmetic surgical procedures around the globe. The breast reconstruction segment is also expected to account for a significant share during the forecast period, 2019–2026.
Based on end user, the global breast implant market can be segmented into hospitals, dermatology clinics & cosmetic centers, and ambulatory surgical centers. Amongst the segments by end user, the hospitals segment is anticipated to be the most lucrative throughout the forecast period, 2019–2026, owing to the increasing number of advanced facilities for cosmetology surgeries. The dermatology clinics & cosmetic centers segment is also expected to witness healthy growth.
The geographical analysis of the market includes major four regions, North America, Europe, Asia Pacific (APAC), Middle East & Africa (LAMEA), and Latin America.
North America leads the breast implants market, owing to the increasing disposable income and growing awareness regarding breast-related cosmetic surgeries. According to the American Society of Plastic Surgeons (ASPS), breast augmentation is one of the top 5 cosmetic procedures conducted in the U.S. The ASPS further stated that over 300,378 breast augmentation procedures had taken place in the U.S. in 2017. A large number of such cases are expected to contribute to the growth of the market in coming years.
The Europe breast implant market is expected to account for a significant market share, owing to the high number of women undergoing cosmetic surgeries and presence of major players in the region.
The Asia Pacific breast implant market is expected to register the highest growth owing to the rising incidences of breast cancer in the region. Moreover, it is expected to grow at the highest CAGR over the forecast period, 2019–2026.
The Middle East & Africa breast implant market is expected to experience significant growth owing to increasing medical tourism and low cost of cosmetic surgeries in the region. Other factors positively influencing the market growth are growing healthcare and cosmetic infrastructure and supportive government initiatives.
Latin America is expected to account for the least share in the global breast implant market due to poor healthcare and cosmetic infrastructure, low per capita income and lack of awareness regarding breast cancer and breast augmentation surgeries.
Major players in the breast implant market are Allergan Inc. (Actavis), CEREPLAS, Establishment Labs S.A., GC Aesthetics Plc., GROUPE SEBBIN SAS, Ideal Implant Inc., Hans Biomed Ltd, Laboratories Arion, Mentor Worldwide LLC. (A Johnson & Johnson Company), POLYTECH Health & Aesthetics GmbH, and Sientra, Inc.
In May 2018, a research study published in Aesthetic Plastic Surgery confirmed reductive augmentation for women who want a higher, rounder breast after reduction surgery. Dr. Jon Mendelsohn, a part of a team that performs breast implant surgery, said implants help lift the sagging breast. Silicone is highly synthetic and thus, silicone implants often lead to irritation and infection. The German biotech company, AMSilk bioengineered a silk coating specifically for medical and cosmetic implants, which scientists believe will lead to better outcomes from implant surgeries.
In 2017, Dr. Niamh O’Halloran of The National University of Ireland Galway was awarded the Allergan Innovation Award for her work on the use of hydrogels in adipose tissue engineering for breast regeneration. Currently, Dr. Niamh is using her expertise in biomedical research to offer natural implants to women who have undergone a mastectomy.
This report offers key insights pertaining to the breast implants market with emphasis on recent developments across geographies and development strategies adopted by prominent market participants. The following sections have specifically been covered in the report.
By End User